News

NULL

Yu is recognized for his pioneering work in synthetic organic chemistry.

Scripps Research scientists discovered that a chemically modified protein puts the brain’s immune cells in a state of damaging, chronic overactivation—and that blocking it protects brain cell connections.

Scripps Research scientists and colleagues develop a nanodisc platform that offers a clearer view of how key viral proteins interact with antibodies.

Funding will expand methods for studying viral proteins and immune responses in more realistic settings for HIV and other severe pathogens.

Scripps Research chemists solve a longstanding problem in the construction of branched molecular frameworks, unlocking a faster path to the complex structures found in drugs and materials.

The doctoral program also placed #7 in Chemistry in the publication’s latest issue ranking top science graduate schools.

Discovery reshapes understanding of how tumor cells repair broken DNA, pointing toward more precise cancer therapies.

First-in-class molecules block a specific protein interaction in immune cells, offering a potential targeted approach to autoimmune diseases like lupus and rheumatoid arthritis.

Researchers will investigate how a common dietary nutrient may control a hidden layer of gene regulation in cancer cells.

New findings from Scripps Research show that changes in protein shape—rather than quantity of proteins—offer a potential new way to detect and track Alzheimer’s disease.

Scripps Research scientists offer new insight into how the body detects light touch and how disruptions in that process may contribute to sensory disorders.

Scripps Research scientists reengineer critical proteins on the surface of HCV, paving the way for a new vaccine design.

Kiani brings decades of experience in patient safety and public service.

Scripps Research scientists and colleagues show how drugs that eliminate certain disease-driving proteins can be discovered systematically rather than by chance.

Scripps Research scientists discover that some membrane-less compartments are built from tiny filaments—a finding that could shape drug development.

Scripps Research and UC San Diego scientists used a novel method to show that some memory neurons produce proteins at higher rates than others.

Partnering to speed up the discovery of new malaria drugs that target parasite cytoskeletal pathways, with a focus on global access and affordability.

Irvine is recognized for his work in empowering the immune system to fight disease, which includes enhancing vaccines against HIV and cancer. 

Modified molecule shows diminished respiratory depression—the leading cause of opioid overdose deaths—while retaining full pain-blocking capability.

Scripps Research scientists designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus.

Measuring membrane thickness was previously only possible in artificial membranes—now scientists can do it inside intact cells, providing crucial context for understanding how cells work.

How consumers’ digital activity trackers could enable personalized health screening and early intervention for cardiovascular health and beyond.

Experiments show how dependence on alcohol rewires the brain's "go" and "stop drinking" signaling systems, with implications for preventing relapse.